[Feasibility and safety of same-day discharge after elective transcatheter interventions: experience of a high-volume center].

Fattibilità e sicurezza della dimissione in giornata per procedure elettive di cardiologia interventistica in un centro ad alto volume.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Aug 2021
Historique:
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 16 10 2021
Statut: ppublish

Résumé

Safety of same-day discharge (SSD) after percutaneous coronary interventions (PCI) has been demonstrated in several studies. However, SDD is rarely adopted in Italy, with a potential waste of resources and decrease of patient satisfaction. In 2019 we implemented a strategy of SDD for all elective coronary procedures admitted to our Radial Unit. Patients were excluded from SDD in case of contraindications for radial access, known contrast allergy, known left main disease based on previous angiogram or coronary computed tomography scan, chronic total occlusions considered as target of revascularization. We assessed the feasibility and safety of this approach in consecutive patients treated at Humanitas Research Center. Out of 366 patients who were admitted electively to our Radial Unit, 152 (41.5%) underwent only diagnostic coronary angiography, while 214 underwent PCI. As expected, radial access was used in the vast majority of cases (361; 98.6%). Patients were mostly discharged in the same day (268; 73%), both after diagnostic (96.7%) and interventional (56.5%) procedures. Patients that were hospitalized at least for one night were older, had a higher cardiovascular risk profile and had a more complex coronary anatomy (left main or proximal left anterior descending artery disease, bifurcations, total occlusions). There were no significant differences between patients discharged and those who were admitted overnight with regards to 7- and 30-day hospital readmission. SSD is safe and feasible in the majority of patients after elective coronary procedures (both diagnostic angiography and PCI), and is not associated with increased hospital readmission at 7 and 30 days. On the basis of the current study, a wider SDD program will be implemented in 2020.

Sections du résumé

BACKGROUND BACKGROUND
Safety of same-day discharge (SSD) after percutaneous coronary interventions (PCI) has been demonstrated in several studies. However, SDD is rarely adopted in Italy, with a potential waste of resources and decrease of patient satisfaction.
METHODS METHODS
In 2019 we implemented a strategy of SDD for all elective coronary procedures admitted to our Radial Unit. Patients were excluded from SDD in case of contraindications for radial access, known contrast allergy, known left main disease based on previous angiogram or coronary computed tomography scan, chronic total occlusions considered as target of revascularization. We assessed the feasibility and safety of this approach in consecutive patients treated at Humanitas Research Center.
RESULTS RESULTS
Out of 366 patients who were admitted electively to our Radial Unit, 152 (41.5%) underwent only diagnostic coronary angiography, while 214 underwent PCI. As expected, radial access was used in the vast majority of cases (361; 98.6%). Patients were mostly discharged in the same day (268; 73%), both after diagnostic (96.7%) and interventional (56.5%) procedures. Patients that were hospitalized at least for one night were older, had a higher cardiovascular risk profile and had a more complex coronary anatomy (left main or proximal left anterior descending artery disease, bifurcations, total occlusions). There were no significant differences between patients discharged and those who were admitted overnight with regards to 7- and 30-day hospital readmission.
CONCLUSIONS CONCLUSIONS
SSD is safe and feasible in the majority of patients after elective coronary procedures (both diagnostic angiography and PCI), and is not associated with increased hospital readmission at 7 and 30 days. On the basis of the current study, a wider SDD program will be implemented in 2020.

Identifiants

pubmed: 34310569
doi: 10.1714/3641.36222
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

657-664

Auteurs

Francesco Condello (F)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Gennaro Petriello (G)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Fausto Roccasalva (F)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Luca Ponte (L)

Direzione Generale e Gestione Operativa, Humanitas Research Center, IRCCS, Rozzano (MI).

Umberto Regalbuto (U)

Direzione Generale e Gestione Operativa, Humanitas Research Center, IRCCS, Rozzano (MI).

Monica Bocciolone (M)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Carlo Pivato (C)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Ottavia Cozzi (O)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Gaia Gasparini (G)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Gabriele Gasparini (G)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Giulio Stefanini (G)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Paolo Pagnotta (P)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Riccardo Bui (R)

Direzione Generale e Gestione Operativa, Humanitas Research Center, IRCCS, Rozzano (MI).

Luciano Ravera (L)

Direzione Generale e Gestione Operativa, Humanitas Research Center, IRCCS, Rozzano (MI).

Bernhard Reimers (B)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Damiano Regazzoli (D)

Cardio Center, Humanitas Clinical and Research Center, IRCCS, Rozzano (MI).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH